Drug Profile
IDP 124
Alternative Names: IDP-124Latest Information Update: 27 May 2021
Price :
$50
*
At a glance
- Originator Valeant Pharmaceuticals International
- Developer Ortho Dermatologics
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 27 May 2021 Discontinued - Phase-III for Atopic dermatitis (In adolescents, In children, In the elderly, In volunteers, In adults) in USA (Topical, Lotion)
- 27 May 2021 Discontinued - Phase-III for Atopic dermatitis in USA (Topical, Lotion)
- 19 Aug 2020 Bausch Health Americas completes the phase III trial Atopic dermatitis (In children, In adults, In elderly) in US (Topical, Lotion) (NCT03058783)